Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biotec Expands Ultra Low Temperature Storage Space
Biotec Services said that the ultra low temperature storage space is increased to 300% which is expected to meet the needs of its clients who use its import,
Biotec Services said that the ultra low temperature storage space is increased to 300% which is expected to meet the needs of its clients who use its import,
Noscira claimed that Phase IIa trial, which was conducted at three centres in Germany considering an advice from experts at the European Medicines Agency (EMA), is the first
Zonisamide is a sulfonamide anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures for adults; infantile spasm, mixed seizure types of Lennox-Gastaut syndrome, myoclonic,
Tekmira’s US-based affiliated office based in Washington state, Protiva, is expected to receive more than 15% of the estimated value of this award, as a subcontract. As per
The HER-2 Study is led by the Cancer Institute and Hospital of the Chinese Academy of Medical Sciences with Dr Yuankai Shi as the principal investigator. China Medical
The USP and National Formulary (USP-NF) is the US legally recognised standards compendia for drugs, drug products and dietary supplements. Dr Foster, as the chairman of the committee
Merz Aesthetics said that Asclera was shown to be effective in treating sclerotherapy, in a study published in the June issue of Phlebology. Merz Aesthetics’ Asclera was approved
The drug development work is supported by a Seeding Drug Discovery Award from the Wellcome Trust, to a team of researchers led by David Wynick, professor of molecular
MediTouch is an EHR used by physicians and is designed for practices of all sizes. HealthFusion claimed that the software offers intuitive and touch screen charting interface and
Tamsulosin hydrochloride extended-release capsules are marketed under the trade names Flomax, Flomaxtra and Urimax, though generic non-modified release capsules are still approved and marketed in many countries, such